Non-Clear Cell Renal Cell Carcinoma: Current Management and Best Practice

The treatment of metastatic renal cell carcinoma (mRCC) has evolved markedly over the past several decades; first with the introduction of targeted therapies and more recently with data supporting checkpoint inhibition. However, the vast majority of studies to date have explored the benefit of agent...

Descripción completa

Detalles Bibliográficos
Autores principales: Salgia, Meghan, Adashek, Jacob, Bergerot, Paulo, Pal, Sumanta K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179117/
https://www.ncbi.nlm.nih.gov/pubmed/30334011
http://dx.doi.org/10.3233/KCA-170019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179117/
https://www.ncbi.nlm.nih.gov/pubmed/30334011
http://dx.doi.org/10.3233/KCA-170019

Ejemplares similares